Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Bayer enters into strategic partnership with Covance
July 2012
SHARING OPTIONS:

BERLIN—On May 30, Bayer HealthCare and contract research organization Covance Inc. announced their establishment of a long-term strategic partnership in the area of clinical drug development, including R&D services related to Phase II to IV clinical studies and central laboratory services.

Bayer HealthCare said its goal is "to better leverage Covance's broad range of experience and services across the R&D portfolio to attain best-in-class operational delivery, efficiency and quality, while also delivering significant financial benefits to both organizations."  
 
"This agreement marks a significant milestone in strengthening our relationship with Covance, which we have built over several years, and provides an opportunity for both partners to develop a broader-based partnership in the future to deliver mutual benefits to both organizations," said Kemal Malik, head of global development at Bayer HealthCare.
 
"We are extremely proud to have established an enduring relationship with Bayer HealthCare built on trust and proven performance that is now elevating to a strategic partnership," said John Watson, president of strategic partnering and chief commercial officer at Covance. "We look forward to working together with Bayer HealthCare to identify opportunities to leverage our broad portfolio to generate more efficiencies, thereby reducing the overall time and cost of drug development."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.